Open AccessPercutaneous laser ablation: a new contribution to unresectable high-risk metastatic retroperitoneal lesions?
Author(s) -
Tianan Jiang,
Zhuang Deng,
Guo Tian,
Fen Chen,
Haiwei Bao,
Li Ju,
Weilin Wang
Publication year - 2016
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.13897
Subject(s) - medicine , ablation , lymph , radiology , percutaneous , retroperitoneal space , metastatic carcinoma , malignancy , metastasis , surgery , carcinoma , cancer , pathology
Metastasis in retroperitoneal lymph nodes is one of the signs of advanced stage or terminal stage of malignancy. We performed a trial to assess the safety and efficacy of ultrasonography (US)-guided local neodymium-doped yttrium aluminum garnet (Nd:YAG) laser ablation for metastatic lymph nodes in the retroperitoneal region.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom